Growth Hormone Peptides
GHRH analogs and GH secretagogues that stimulate the pituitary to increase natural GH production.
Growth hormone peptides are a class of compounds that stimulate the pituitary gland to produce and release growth hormone through natural physiological mechanisms. Unlike exogenous HGH, these peptides work within the body's own regulatory feedback system. CJC-1295 is a GHRH analog that amplifies GH pulse amplitude, while Ipamorelin and Sermorelin are secretagogues that trigger GH release with varying degrees of selectivity. Tesamorelin provides strong visceral fat reduction data from published clinical trials.
The distinction between GHRH analogs and ghrelin mimetics is important for understanding how to combine these compounds. GHRH analogs (CJC-1295, Sermorelin, Tesamorelin) act on the GHRH receptor to amplify each GH pulse. Ghrelin mimetics (Ipamorelin, GHRP-2) act on the ghrelin receptor (GHS-R1a) to trigger GH release through a separate signal pathway. Combining one from each class produces synergistic GH output far exceeding either alone. Tesamorelin has FDA-approved human equivalents, giving it among the strongest published safety profiles in this category.
All growth hormone peptides in this catalog are available in multiple sizes and concentrations to support different research protocols. They are supplied as lyophilized powder and require reconstitution with bacteriostatic water prior to use. All peptides are provided with a Certificate of Analysis (COA) from an independent third-party laboratory confirming identity and purity. These products are sold strictly for laboratory and educational purposes and are not intended for human use.